Virtus ETF Advisers LLC - Q4 2015 holdings

$36.4 Million is the total value of Virtus ETF Advisers LLC's 76 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was - .

 Value Shares↓ Weighting
MMP NewMAGELLAN MIDSTREAM PRTNRS LP$2,874,00042,311
+100.0%
7.89%
ETP NewENERGY TRANSFER PRTNRS L Pcall$1,855,00055,000
+100.0%
5.09%
BPL NewBUCKEYE PARTNERS L Punit ltd partn$1,642,00024,889
+100.0%
4.51%
WMB NewWILLIAMS COS INC DEL$1,640,00063,805
+100.0%
4.50%
EPD NewENTERPRISE PRODS PARTNERS L$1,426,00055,762
+100.0%
3.91%
WMB NewWILLIAMS COS INC DELcall$1,157,00045,000
+100.0%
3.18%
EPD NewENTERPRISE PRODS PARTNERS Lcall$1,151,00045,000
+100.0%
3.16%
OMER NewOMEROS CORP$696,00044,237
+100.0%
1.91%
KERX NewKERYX BIOPHARMACEUTICALS INC$689,000136,472
+100.0%
1.89%
WES NewWESTERN GAS PARTNERS LP$680,00014,300
+100.0%
1.87%
AEGR NewAEGERION PHARMACEUTICALS INC$656,00064,959
+100.0%
1.80%
SGEN NewSEATTLE GENETICS INC$653,00014,541
+100.0%
1.79%
IONS NewIONIS PHARMACEUTICALS INC$647,00010,447
+100.0%
1.78%
NKTR NewNEKTAR THERAPEUTICS$645,00038,260
+100.0%
1.77%
PGNX NewPROGENICS PHARMACEUTICALS IN$636,000103,807
+100.0%
1.75%
VNDA NewVANDA PHARMACEUTICALS INC$624,00067,021
+100.0%
1.71%
ARNA NewARENA PHARMACEUTICALS INC$614,000323,107
+100.0%
1.68%
ALXN NewALEXION PHARMACEUTICALS INC$604,0003,167
+100.0%
1.66%
GEL NewGENESIS ENERGY L Punit ltd partn$598,00016,278
+100.0%
1.64%
AMGN NewAMGEN INC$592,0003,644
+100.0%
1.62%
PSXP NewPHILLIPS 66 PARTNERS LP$588,0009,581
+100.0%
1.61%
GILD NewGILEAD SCIENCES INC$588,0005,810
+100.0%
1.61%
CELG NewCELGENE CORP$585,0004,884
+100.0%
1.61%
ANAC NewANACOR PHARMACEUTICALS INC$581,0005,147
+100.0%
1.60%
MDCO NewMEDICINES CO$572,00015,331
+100.0%
1.57%
PAA NewPLAINS ALL AMERN PIPELINE Lunit ltd partn$571,00024,737
+100.0%
1.57%
RTRX NewRETROPHIN INC$552,00028,634
+100.0%
1.52%
SE NewSPECTRA ENERGY CORP$422,00017,608
+100.0%
1.16%
CEQP NewCRESTWOOD EQUITY PARTNERS LPunit ltd partner$407,00019,580
+100.0%
1.12%
PAA NewPLAINS ALL AMERN PIPELINE Lcall$347,00015,000
+100.0%
0.95%
ADXS NewADVAXIS INC$334,00033,234
+100.0%
0.92%
ATRA NewATARA BIOTHERAPEUTICS INC$321,00012,137
+100.0%
0.88%
BLCM NewBELLICUM PHARMACEUTICALS INC$306,00015,086
+100.0%
0.84%
RXDX NewIGNYTA INC$303,00022,638
+100.0%
0.83%
PRTK NewPARATEK PHARMACEUTICALS INC$300,00015,819
+100.0%
0.82%
OPHT NewOPHTHOTECH CORP$293,0003,735
+100.0%
0.80%
CARA NewCARA THERAPEUTICS INC$292,00017,299
+100.0%
0.80%
ARWR NewARROWHEAD RESH CORP$292,00047,549
+100.0%
0.80%
GERN NewGERON CORP$288,00059,436
+100.0%
0.79%
PTLA NewPORTOLA PHARMACEUTICALS INC$286,0005,561
+100.0%
0.78%
INSM NewINSMED INC$285,00015,716
+100.0%
0.78%
SRE NewSEMPRA ENERGY$284,0003,017
+100.0%
0.78%
IMMU NewIMMUNOMEDICS INC$284,00092,480
+100.0%
0.78%
SGMO NewSANGAMO BIOSCIENCES INC$282,00030,847
+100.0%
0.77%
CLVS NewCLOVIS ONCOLOGY INC$280,0007,999
+100.0%
0.77%
ACAD NewACADIA PHARMACEUTICALS INC$279,0007,814
+100.0%
0.77%
SRPT NewSAREPTA THERAPEUTICS INC$278,0007,203
+100.0%
0.76%
RLYP NewRELYPSA INC$278,0009,802
+100.0%
0.76%
LJPC NewLA JOLLA PHARMACEUTICAL CO$277,00010,250
+100.0%
0.76%
MGNX NewMACROGENICS INC$276,0008,911
+100.0%
0.76%
ONTY NewONCOTHYREON INC$275,000123,925
+100.0%
0.76%
NVAX NewNOVAVAX INC$274,00032,714
+100.0%
0.75%
LXRX NewLEXICON PHARMACEUTICALS INC$273,00020,486
+100.0%
0.75%
TSRO NewTESARO INC$273,0005,210
+100.0%
0.75%
NLNK NewNEWLINK GENETICS CORP$272,0007,484
+100.0%
0.75%
TRVN NewTREVENA INC$268,00025,478
+100.0%
0.74%
RDUS NewRADIUS HEALTH INC$267,0004,345
+100.0%
0.73%
MACK NewMERRIMACK PHARMACEUTICALS IN$265,00033,570
+100.0%
0.73%
LOXO NewLOXO ONCOLOGY INC$263,0009,258
+100.0%
0.72%
SGYPQ NewSYNERGY PHARMACEUTICALS DEL$261,00046,043
+100.0%
0.72%
DTE NewDTE ENERGY CO$260,0003,248
+100.0%
0.71%
ALDR NewALDER BIOPHARMACEUTICALS INC$255,0007,728
+100.0%
0.70%
CNCE NewCONCERT PHARMACEUTICALS INC$255,00013,456
+100.0%
0.70%
DVAX NewDYNAVAX TECHNOLOGIES CORP$251,00010,380
+100.0%
0.69%
ARDX NewARDELYX INC$249,00013,717
+100.0%
0.68%
EIX NewEDISON INTL$242,0004,091
+100.0%
0.66%
AWK NewAMERICAN WTR WKS CO INC NEW$186,0003,112
+100.0%
0.51%
ITC NewITC HLDGS CORP$180,0004,598
+100.0%
0.49%
CMS NewCMS ENERGY CORP$173,0004,802
+100.0%
0.48%
ATO NewATMOS ENERGY CORP$167,0002,651
+100.0%
0.46%
PNW NewPINNACLE WEST CAP CORP$118,0001,836
+100.0%
0.32%
AEP NewAMERICAN ELEC PWR INC$117,0002,012
+100.0%
0.32%
POR NewPORTLAND GEN ELEC CO$77,0002,105
+100.0%
0.21%
SO NewSOUTHERN CO$39,000837
+100.0%
0.11%
OKE NewONEOK INC NEW$33,0001,356
+100.0%
0.09%
SHLX NewSHELL MIDSTREAM PARTNERS L Punit ltd int$29,000689
+100.0%
0.08%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERTEX PHARMACEUTICALS INC31Q3 20231.7%
REGENERON PHARMACEUTICALS31Q3 20231.8%
INCYTE CORP31Q3 20232.1%
ENANTA PHARMACEUTICALS INC31Q3 20232.2%
EXELIXIS INC31Q3 20231.8%
VANDA PHARMACEUTICALS INC31Q3 20231.7%
IRONWOOD PHARMACEUTICALS INC31Q3 20232.0%
LIGAND PHARMACEUTICALS INC31Q3 20231.5%
GILEAD SCIENCES INC31Q3 20231.6%
HALOZYME THERAPEUTICS INC31Q3 20231.7%

View Virtus ETF Advisers LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-15
13F-HR2023-11-07
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Virtus ETF Advisers LLC's complete filings history.

Compare quarters

Export Virtus ETF Advisers LLC's holdings